维普期刊资源整合服务平台（V6.5）

88篇 您的检索式：作者名="Labenz J"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Proposed approach to the challenging management of progressive gastroesophageal reflux disease显示文摘The progression of gastroesophageal reflux disease(GERD) in patients who are taking proton pump inhibitors(PPIs) has been reported by several investigators,leading to concerns that PPI therapy does not address all aspects of the disease.Patients who are at risk of progression need to be identified early in the course of their disease in order to receive preventive treatment.A review of the literature on GERD progression to Barrett's esophagus and the associated physiological and pathological changes was performed and risk factors for progression were identified.In addition,a potential approach to the prevention of progression is discussed.Current evidence shows that GERD can progress;however,patients at risk of progression may not be identified early enough for it to be prevented.Biopsies of the squamocolumnar junction that show microscopic intestinalization of metaplastic cardiac mucosa in endoscopically normal patients are predictive of future visible Barrett's esophagus,and an indicator of GERD progression.Such changes can be identified only through biopsy,which is not currently recommended for endoscopically normal patients.GERD treatment should aim to prevent progression.We propose that endoscopically normal patients who partially respond or do not respond to PPI therapy undergo routine biopsies at the squamocolumnar junction to identify histological changes that may predict future progression.This will allow earlier intervention,aimed at preventing Barrett's esophagus.	Joachim Labenz Parakrama T Chandrasoma Laura J Knapp Tom R DeMeester	2018	World Journal of Gastrointestinal Endoscopy2018，10，9：	7
2	Comparison of esomeprazole 40mg once daily for the healing of reflux esophagitis 显示文摘	Labenz J Naucler E Eklund A	2003	Gut2003，52，1：	1
3	Helicobacter pylori therapy with omeprazole and cllarithromycin:current stattus显示文摘	Labenz J	1994	Leber Magen Dann1994，24，5：	1
4	Long term clinical course of ulcer Disease and incidence of reflux oesophagitis in a large cohort of duodenal ulcer patients followed after eradication of Helicobacter pylori显示文摘	Labenz J Tillenburg B Peitz U	1995	Gut1995，37，：	1
5	A randormizeel comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis the' EXPO study显示文摘	Labenz J Armstrong D Lauritson K	2005	Aliment pharmacol ther2005，21，6：	1
6	Preva- lence of extra-oesophageal manifestations in gastro-oe- sophageal reflux disease: an analysis based on the ProGERD study显示文摘	JASPERSEN D KULIG M LABENZ J	2003	Aliment Pharmacol Ther2003，17，：	1
7	Lifestyle factors and symptoms of gastro-oesophageal reflux:a population-based study显示文摘	Nocon M Labenz J Willich SN	2006	Aliment Pharmacol Ther2006，23，1：	1
8	Prevalence of extra-oesophageal manifestations in gastre-oesophageal reflux disease: an analysis based on the ProGERD Study显示文摘	Jaspersen D Kulig M Labenz J	2003	Aliment Pharmacol Ther2003，17，12：	1
9	Lifestyle factors and symptoms of gastro-cesophngeal reflux-a-population-based study显示文摘	NOCON M LABENZ J WILLICH SN	2006	Aliment Pharmacol Ther2006，23，：	1
10	Helicobactcr pylori and gastric cancer: current status of the Austrain Czech German gastric cancer prevention trial (PRISMA-Study)显示文摘	Miehlke S Kirsch C Dragosics B Gschwantler M Oberhuber G Antos D Dite P Luter J Labenz J Leodolter A Malfertheiner P Ncubauer A Ehninger G Stolte M Bayerd rffer E	2001	World J Gastroenterol2001，7，：	1
11	Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeging; a prospective randomized controlled study显示文摘	Labenz J Peitz U Leusing C	1997	Gut1997，40，1：	1
12	What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa显示文摘	Vieth M Peitz U Labenz J	2004	Dig Dis2004，22，2：	1
13	Short term triple therapy with pantoprazole , clarithromycin and metronidazole in eradication of Helicobacter pylori显示文摘	Labenz J Peitz U Tillenburg B	1995	Leber Magen Darm1995，25，3：	1
14	Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease : an analysis based on the ProGERD study 显示文摘	Jaspersen D Kulig M Labenz J	2003	Ailment Pharmacol Ther2003，17，12：	1
15	Evidence for the essential role of Helicobacter pylori in gastric ulcer disease显示文摘	Labenz J B?rsch G		0，，：	1
16	Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcers显示文摘	Morgner A Miehlke S Labenz J	2007	Expert Opin Pharmacother2007，8，7：	1
17	Nighttime heartburn in patients with gastreosopbegeal reflux disease under routine care显示文摘	Nocon M Labenz J Jaspersen D	2008	Digestion2008，77，2：	1
18	Risk factors for erosive esophagitis:A Multivariate analysis based on the ProGERD study initiative显示文摘	Labenz J Jaspersen D Kulig M	2004	Am J Gastroenterol2004，99，9：	1
19	Curing helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophgatitis显示文摘	Labenz J Blum AL Bayerd?rffer E	1997	Gastroenterology1997，112，：	1
20	Esomprazole prevention and treatment of NSAID - induced symptoms and ulcers显示文摘	Morgner A Miehlke S Labenz J	2007	Ex- pert Opin Pharmacother2007，8，7：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示